The 6th World Congress on Targeting Phage Therapy is to be held again on June 1-2, 2023 in Paris, France.
The major aim behind Targeting Phage Therapy 2023 is to cover the aspects of phage therapy today, especially with the emergence of antibiotic resistance. It will also shed light on the new bacteriophage-based innovations and discoveries.
The First Speakers
Farzaneh Moghtader, Istinye University, Turkey – Combined Therapies for Severely Infected Wounds: Multifunctional Bio-hybrids Composed of Gelatine Microspheres Carrying Bacteriophages and/or bFGF and their Aggregates with Mesenchymal Stem Cells
Anna Pistocchi, Università degli Studi di Milano, Italy – Investigating the Therapeutic Potential of Phages as Antibacterials and Immunomodulators in a Zebrafish Model of Cystic Fibrosis
Rodrigo Ibarra Chavez, University of Copenhagen, Denmark – Phage-inducible Chromosomal Islands Promote Genetic Variability by Blocking Phage Reproduction
Lilian Musila, U.S. Army Medical Research Directorate-Africa, Kenya – Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations
Domenico Frezza, University of Roma Tor Vergata, Italy – Phage Therapy: Vision and Gaps
Noemi Poerio, University of Rome “Tor Vergata”, Italy – A Novel Combined Host- and Pathogen-Directed Therapeutic Approach to Fight Infections by MDR- Klebsiella pneumoniae
Willem-Jan Metsemakers, KU Leuven, Belgium – The Use of Bacteriophage Therapy for Difficult-to-Treat Musculoskeletal Infections: the PHAGEFORCE Experience
Alexander Sulakvelidze, President and CEO of Intralytix, Inc., Colombia – Modern Approaches for Optimizing Therapeutic Phage Preparations
Abstract Submission
Deadline for Oral Presentation Submission: May 11, 2023
Deadline for Poster Presentation Submission: May 15, 2023
Registration
Targeting Phage and Antibiotic Resistance will be hybrid. You can choose to register for in-person participation or online participation.
Contact
You can reach out to the organizing committee and scientific committee for more information via email: contact[at]tid-site.com